Prosecution Insights
Prosecution Insights
10 pending office actions • 9 art units • 10 examiners • 0 of 10 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (10%) |
| §103 only | 2 (20%) |
| §112 only | 1 (10%) |
| Double-patenting + other | 1 (10%) |
| Multi-statute (no §101) | 5 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SWIER, WAYNE K. | 1 | 67.5% | +19.2% |
| MENON, KRISHNAN S | 1 | 59.8% | +11.5% |
| SHIM, DAVID M. | 1 | 57.8% | +55.9% |
| PIPIC, ALMA | 1 | 54.3% | +55.2% |
| COFFA, SERGIO | 1 | 61.1% | +33.2% |
| SCHACHERMEYER, SAMANTHA LYNN | 1 | 36.1% | +70.8% |
| LIPPOLIS, ALEXANDRA ROSE | 1 | 39.3% | +70.3% |
| ZHANG, KELING NMN | 1 | 65.6% | +17.2% |
| FRITCHMAN, REBECCA M | 1 | 45.7% | +35.8% |
| WOZNICKI, JACQUELINE | 1 | 49.7% | +26.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17760249 | Detection of Lipid Markers | FRITCHMAN, REBECCA M | 43d overdue |
| 18856983 | PROCESS AND DEVICE FOR ASSEMBLY OF VAN DER WAALS HETEROSTRUCTURES | SWIER, WAYNE K. | — |
| 18837581 | Method and Apparatus for Mineral Extraction | MENON, KRISHNAN S | — |
| 18269147 | HYALURONAN IS A DRIVER OF COVID-19 SEVERITY | SCHACHERMEYER, SAMANTHA LYNN | — |
| 17754721 | MODULATING OPSIN SIGNALING LIFETIME FOR OPTOGENETIC APPLICATIONS | LIPPOLIS, ALEXANDRA ROSE | — |
| 18000855 | GRAPHITE DECONTAMINATION | ZHANG, KELING NMN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17438345 | TISSUE REPAIR SCAFFOLD AND DEVICE | WOZNICKI, JACQUELINE | 44d overdue |
| 17760249 | Detection of Lipid Markers | FRITCHMAN, REBECCA M | 43d overdue |
| 17926847 | ANTIVIRAL POLYMERS | PIPIC, ALMA | 25d overdue |
| 18291809 | 6-SUBSTITUTED NAPHTHALENE-1,3-DISULFONIC ACID DERIVATIVES AS MODULATORS OF THE EXTRACELLULAR NICOTINAMIDE PHOSPHORIBOSYL TRANSFERASE (ENAMPT) FOR THE TREATMENT OF E.G. DIABETES | SHIM, DAVID M. | 12d |
| 18856983 | PROCESS AND DEVICE FOR ASSEMBLY OF VAN DER WAALS HETEROSTRUCTURES | SWIER, WAYNE K. | — |
| 18837581 | Method and Apparatus for Mineral Extraction | MENON, KRISHNAN S | — |
| 18262113 | USE OF LINK-TSG6 FOR THE TREATMENT OF OSTEOARTHRITIC PAIN | COFFA, SERGIO | — |
| 18269147 | HYALURONAN IS A DRIVER OF COVID-19 SEVERITY | SCHACHERMEYER, SAMANTHA LYNN | — |
| Art Unit | Apps |
|---|---|
| 1748 | 1 |
| 1626 | 1 |
| 1617 | 1 |
| 1658 | 1 |
| 1693 | 1 |
| 1637 | 1 |
| 1732 | 1 |
| 1758 | 1 |
| 3774 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18856983 | PROCESS AND DEVICE FOR ASSEMBLY OF VAN DER WAALS HETEROSTRUCTURES | SWIER, WAYNE K. | 1748 | §102§103 | Non-Final OA | — | Pending | Oct 15, 2024 |
| 18837581 | Method and Apparatus for Mineral Extraction | MENON, KRISHNAN S | — | §102§103§112 | Non-Final OA | — | Pending | Aug 09, 2024 |
| 18291809 | 6-SUBSTITUTED NAPHTHALENE-1,3-DISULFONIC ACID DERIVATIVES AS MODULATORS OF THE EXTRACELLULAR NICOTINAMIDE PHOSPHORIBOSYL TRANSFERASE (ENAMPT) FOR THE TREATMENT OF E.G. DIABETES | SHIM, DAVID M. | 1626 | §112 | Non-Final OA | 12d | Pending | Jan 24, 2024 |
| 17926847 | ANTIVIRAL POLYMERS | PIPIC, ALMA | 1617 | §103 | Final Rejection | 25d overdue | Pending | Jul 19, 2023 |
| 18262113 | USE OF LINK-TSG6 FOR THE TREATMENT OF OSTEOARTHRITIC PAIN | COFFA, SERGIO | 1658 | §102§103§112DPOther | Final Rejection | — | Pending | Jul 19, 2023 |
| 18269147 | HYALURONAN IS A DRIVER OF COVID-19 SEVERITY | SCHACHERMEYER, SAMANTHA LYNN | 1693 | §101§102§103§112 | Final Rejection | — | Pending | Jun 22, 2023 |
| 17754721 | MODULATING OPSIN SIGNALING LIFETIME FOR OPTOGENETIC APPLICATIONS | LIPPOLIS, ALEXANDRA ROSE | 1637 | §102§112 | Non-Final OA | — | Pending | Apr 21, 2023 |
| 18000855 | GRAPHITE DECONTAMINATION | ZHANG, KELING NMN | 1732 | §102§103§112 | Non-Final OA | — | Pending | Dec 06, 2022 |
| 17760249 | Detection of Lipid Markers | FRITCHMAN, REBECCA M | 1758 | §103§112 | Final Rejection | 43d overdue | Pending | Aug 05, 2022 |
| 17438345 | TISSUE REPAIR SCAFFOLD AND DEVICE | WOZNICKI, JACQUELINE | 3774 | §103 | Final Rejection | 44d overdue | Pending | Sep 10, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial